| Literature DB >> 31452684 |
William G Henderson1,2,3, Michael R Bronsert1,2, Karl E Hammermeister1,2,4, Anne Lambert-Kerzner1,2,5, Robert A Meguid1,2,6.
Abstract
BACKGROUND: The Surgical Risk Preoperative Assessment System (SURPAS) is a parsimonious set of models providing accurate preoperative prediction of common adverse outcomes for individual patients. However, focus groups with surgeons and patients have developed a list of questions about and recommendations for how to further improve SURPAS's usability and usefulness. Eight issues were systematically evaluated to improve SURPAS.Entities:
Year: 2019 PMID: 31452684 PMCID: PMC6702720 DOI: 10.1186/s13037-019-0208-2
Source DB: PubMed Journal: Patient Saf Surg ISSN: 1754-9493
Fig. 2SURPAS Documentation Screen
Fig. 3SURPAS Patient handout, abbreviated
Fig. 4SURPAS About section
Comparison of Discrimination and Calibration of the Full Eight Variable SURPAS Model with Models without Systemic Sepsisa
| Adverse outcome | C-index | Brier Score | ||||
|---|---|---|---|---|---|---|
| Full Model | Full Model with No Systemic Sepsis | Difference | Full Model | Full Model with No Systemic Sepsis | Difference | |
| 30-day mortality | 0.926 | 0.922 | −0.004 | 0.0102 | 0.0103 | 0.0001 |
| Morbidity | 0.801 | 0.793 | −0.008 | 0.0904 | 0.0922 | 0.0018 |
| Readmission | 0.699 | 0.698 | −0.001 | 0.0488 | 0.0489 | 0.0001 |
| Infection | 0.774 | 0.761 | −0.013 | 0.0445 | 0.0450 | 0.0005 |
| Bleeding/Transfusion | 0.850 | 0.846 | −0.004 | 0.0419 | 0.0421 | 0.0002 |
| Pulmonary | 0.890 | 0.882 | −0.008 | 0.0228 | 0.0237 | 0.0009 |
| UTI | 0.750 | 0.749 | −0.001 | 0.0145 | 0.0145 | 0.0000 |
| VTE | 0.765 | 0.760 | −0.005 | 0.0086 | 0.0086 | 0.0000 |
| Cardiac | 0.869 | 0.866 | −0.003 | 0.0062 | 0.0062 | 0.0000 |
| Renal | 0.859 | 0.853 | −0.006 | 0.0059 | 0.0059 | 0.0000 |
| Neurologic | 0.829 | 0.828 | −0.001 | 0.0021 | 0.0021 | 0.0000 |
aAbbreviations: SURPAS Surgical Preoperative Risk Assessment System, UTI Urinary tract infection, VTE Venous thromboembolism
Comparison of Discrimination and Calibration of the Full Eight Variable SURPAS Model with Models without Systemic Sepsis but with the Addition of CPT Specific Event Ratesa
| Adverse outcome | C-index | Brier Score | ||||
|---|---|---|---|---|---|---|
| Full Model | Full Model with CPT Event Rate | Difference | Full Model | Full Model with CPT Event Rate | Difference | |
| 30-day mortality | 0.926 | 0.928 | 0.002 | 0.0102 | 0.0103 | 0.0001 |
| Morbidity | 0.801 | 0.823 | 0.022 | 0.0904 | 0.0880 | −0.0024 |
| Readmission | 0.699 | 0.723 | 0.024 | 0.0488 | 0.0487 | −0.0001 |
| Infection | 0.774 | 0.805 | 0.031 | 0.0445 | 0.0442 | −0.0003 |
| Bleeding/Transfusion | 0.850 | 0.875 | 0.025 | 0.0419 | 0.0408 | −0.0011 |
| Pulmonary | 0.890 | 0.893 | 0.003 | 0.0228 | 0.0233 | 0.0005 |
| UTI | 0.750 | 0.776 | 0.026 | 0.0145 | 0.0145 | 0.0000 |
| VTE | 0.765 | 0.788 | 0.023 | 0.0086 | 0.0086 | 0.0000 |
| Cardiac | 0.869 | 0.871 | 0.002 | 0.0062 | 0.0062 | 0.0000 |
| Renal | 0.859 | 0.863 | 0.004 | 0.0059 | 0.0059 | 0.0000 |
| Neurologic | 0.829 | 0.840 | 0.011 | 0.0021 | 0.0021 | 0.0000 |
aAbbreviations: SURPAS Surgical Preoperative Risk Assessment System, UTI Urinary tract infection, VTE Venous thromboembolism
Comparison of Discrimination and Calibration of the SURPAS without Systemic Sepsis but with the Addition of CPT Specific Event Rates with Models adding an Indicator for Multiple CPTsa
| Adverse outcome | C-index | Brier Score | ||||
|---|---|---|---|---|---|---|
| Full Model with CPT Event Rate | Same Model plus Multiple CPT Indicator | Difference | Full Model with CPT Event Rate | Same Model plus Multiple CPT Indicator | Difference | |
| 30-day mortality | 0.928 | 0.929 | 0.001 | 0.0103 | 0.0103 | 0.0000 |
| Morbidity | 0.823 | 0.824 | 0.001 | 0.0880 | 0.0876 | −0.0004 |
| Readmission | 0.723 | 0.723 | 0.000 | 0.0487 | 0.0487 | 0.0000 |
| Infection | 0.805 | 0.806 | 0.001 | 0.0442 | 0.0441 | −0.0001 |
| Bleeding/Transfusion | 0.875 | 0.877 | 0.002 | 0.0408 | 0.0406 | −0.0002 |
| Pulmonary | 0.893 | 0.894 | 0.001 | 0.0233 | 0.0232 | −0.0001 |
| UTI | 0.776 | 0.777 | 0.001 | 0.0145 | 0.0145 | 0.0000 |
| VTE | 0.788 | 0.789 | 0.001 | 0.0086 | 0.0086 | 0.0000 |
| Cardiac | 0.871 | 0.871 | 0.000 | 0.0062 | 0.0062 | 0.0000 |
| Renal | 0.863 | 0.865 | 0.002 | 0.0059 | 0.0059 | 0.0000 |
| Neurologic | 0.840 | 0.84 | 0.000 | 0.0021 | 0.0021 | 0.0000 |
aAbbreviations: SURPAS Surgical Preoperative Risk Assessment System, UTI Urinary tract infection, VTE Venous thromboembolism
Order of Entry of Predictor Variables in the Final SURPAS Models and C-indexes and Brier Scores for the Development and Test Datasets in the Internal Validation Study
| Characteristicsa | 30-day Mortality | Morbidity | Unplanned Readmission | Respiratory | Infection | UTI | VTE | Cardiac | Bleeding | Renal | Stroke | Average Rank |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CPT-specific event rate | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1.2 |
| ASA class | 1 | 2 | 2 | 2 | 3 | 2 | 3 | 1 | 2 | 2 | 2 | 2.0 |
| Inpatient/outpatient | 6 | 3 | 3 | 3 | 2 | 3 | 2 | 4 | 3 | 3 | 4 | 3.3 |
| Primary surgeon specialty | 7 | 4 | 4 | 6 | 4 | 4 | 6 | 6 | 4 | 4 | 5 | 4.9 |
| Age (years) | 4 | 7 | 7 | 7 | 6 | 5 | 4 | 3 | 5 | 7 | 3 | 5.3 |
| Functional health status | 3 | 5 | 5 | 4 | 7 | 6 | 5 | 7 | 8 | 6 | 6 | 5.6 |
| Emergency operation | 5 | 6 | 8 | 5 | 5 | 8 | 7 | 5 | 7 | 5 | 7 | 6.2 |
| Work relative value unit | 8 | 8 | 6 | 8 | 8 | 7 | 8 | 8 | 6 | 8 | 8 | 7.5 |
| Model c-index | 0.928 | 0.823 | 0.724 | 0.893 | 0.805 | 0.777 | 0.788 | 0.871 | 0.875 | 0.863 | 0.839 | |
| Model Brier score | 0.0103 | 0.0879 | 0.0485 | 0.0234 | 0.0438 | 0.0145 | 0.0086 | 0.0062 | 0.0406 | 0.0060 | 0.0021 | |
| Validation c-index | 0.931 | 0.823 | 0.724 | 0.893 | 0.805 | 0.776 | 0.790 | 0.877 | 0.876 | 0.870 | 0.875 | |
| Validation Brier score | 0.0102 | 0.0880 | 0.0483 | 0.0232 | 0.0437 | 0.0144 | 0.0086 | 0.0063 | 0.0407 | 0.0059 | 0.0020 |
aAbbreviations: ASA class American Society of Anesthesiology physical status classification, CPT Current Procedural Terminology, SURPAS Surgical Preoperative Risk Assessment System, UTI Urinary tract infection, VTE Venous thromboembolism
Fig. 1SURPAS Input and Output Screen